Ptc Therapeutics (PTCT) Non Operating Income (2012 - 2026)

Ptc Therapeutics' Non Operating Income history runs 15 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Non Operating Income rose 125.52% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $8.9 million (up 757.4% YoY), while the FY2025 annual figure was $974000.0, down 85.12% from the prior year.
• Non Operating Income was $1.6 million for Q1 2026 at Ptc Therapeutics, down from $6.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $35.1 million in Q4 2022 to a low of -$38.1 million in Q3 2022.
• Historically, Non Operating Income has averaged -$1.8 million across 5 years, with a median of $1.5 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income sank 1183.82% in 2022, then soared 447.33% in 2025.
• A 5-year view of Non Operating Income shows it stood at $35.1 million in 2022, then tumbled by 46.05% to $19.0 million in 2023, then tumbled by 53.33% to $8.8 million in 2024, then slipped by 26.4% to $6.5 million in 2025, then plunged by 75.3% to $1.6 million in 2026.
• The last three Non Operating Income figures came in at $1.6 million (Q1 2026), $6.5 million (Q4 2025), and $6.5 million (Q3 2025), per Business Quant data.